Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
Alessandro Paciaroni, Valeria Libera, Francesca Ripanti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6062-6062
Open Access | Times Cited: 11

Showing 11 citing articles:

High-Resolution Substrate Specificity Profiling of SARS-CoV-2 Mpro; Comparison to SARS-CoV Mpro
Rasha M. Yaghi, Collin L. Andrews, Dennis Wylie, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 7, pp. 1474-1483
Open Access | Times Cited: 4
AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms
Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 4
Enzyme kinetics model for the coronavirus main protease including dimerization and ligand binding
Van Ngoc Thuy La, Lulu Kang, David D. L. Minh
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis
Asma Fatima, Anupriya M. Geethakumari, Wesam S. Ahmed, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 3
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication
Elisa Bianconi, Anna Gidari, Maria Souma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Protein‐Templated Ugi Reactions versus In‐Situ Ligation Screening: Two Roads to the Identification of SARS‐CoV‐2 Main Protease Inhibitors
Rebekka Wamser, Xinting Zhang, Benno Kuropka, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 17
Open Access | Times Cited: 2
An Investigation of Nirmatrelvir (Paxlovid) Resistance in SARS-CoV-2 Mpro
Rasha M. Yaghi, Dennis Wylie, Collin L. Andrews, et al.
ACS Bio & Med Chem Au (2024) Vol. 4, Iss. 6, pp. 280-290
Open Access | Times Cited: 2
Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
Marcel Arruda Diogo, Augusto Gomes Teixeira Cabral, Renata Barbosa de Oliveira
Pathogens (2024) Vol. 13, Iss. 10, pp. 825-825
Open Access | Times Cited: 1
Discovery of a Nasal Spray Steroid, Tixocortol, as an Inhibitor of SARS-CoV-2 Main Protease and Viral Replication
David A. Davis, Ashwin Nair, Yana Astter, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Identification of Natural Inhibitors of SARS-CoV-2 Main Protease (Mpro) via Structure-Based Virtual Screening and Molecular Dynamics Simulations

Letters in Applied NanoBioScience (2024) Vol. 13, Iss. 4, pp. 176-176
Open Access
Backstage Heroes—Yeast in COVID-19 Research
Wojciech Grabiński, Andonis Karachitos, Anna Kicińska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12661-12661
Open Access
Page 1

Scroll to top